Normobaric Hypoxia Induces Tolerance to Focal Permanent Cerebral Ischemia in Association with an Increased Expression of Hypoxia-Inducible Factor-1 and its Target Genes, Erythropoietin and VEGF, in the Adult Mouse Brain
Open Access
- 1 April 2002
- journal article
- research article
- Published by SAGE Publications in Journal of Cerebral Blood Flow & Metabolism
- Vol. 22 (4) , 393-403
- https://doi.org/10.1097/00004647-200204000-00003
Abstract
Tolerance to cerebral ischemia is achieved by preconditioning sublethal stresses, such as ischemia or hypoxia, paradigms in which the decrease of O2 availability may constitute an early signal inducing tolerance. In accordance with this concept, this study shows that hypoxia induces tolerance against focal permanent ischemia in adult mice. Normobaric hypoxia (8% O2 of 1-hour, 3-hour, or 6-hour duration), performed 24 hours before ischemia, reduces infarct volume by approximately 30% when compared with controls. To elucidate the mechanisms underlying this neuroprotection, the authors investigated the effects of preconditioning on cerebral expression of hypoxia-inducible factor-1α (HIF-1α) and its target genes, erythropoietin and vascular endothelial growth factor (VEGF). Hypoxia, whatever its duration (1 hour, 3 hours, 6 hours), rapidly increases the nuclear content of HIF-1α as well as the mRNA levels of erythropoietin and VEGF. Furthermore, erythropoietin and VEGF are upregulated at the protein level 24 hours after 6 hours of hypoxia. The authors' findings show that (1) hypoxia elicits a delayed, short-lasting (<72 hours) tolerance to focal permanent ischemia in the adult mouse brain; (2) HIF-1 target genes could contribute to the establishment of tolerance; and (3) this model might be a useful paradigm to further study the mechanisms of ischemic tolerance, to identify new therapeutic targets for stroke.Keywords
This publication has 80 references indexed in Scilit:
- Activation of the Nuclear Factor-κB Is a Key Event in Brain ToleranceJournal of Neuroscience, 2001
- Effect of recombinant human erythropoietin on cerebral ischemia following experimental subarachnoid hemorrhageEuropean Journal of Pharmacology, 2000
- Role of hypoxia-inducible factor-1 in hypoxia-induced ischemic tolerance in neonatal rat brainAnnals of Neurology, 2000
- Neurons and astrocytes express EPO mRNA: Oxygen-sensing mechanisms that involve the redox-state of the brainGlia, 2000
- Induction of hypoxia‐inducible factor‐1 (HIF‐1) and its target genes following focal ischaemia in rat brainEuropean Journal of Neuroscience, 1999
- NMDA receptor antagonism, but not AMPA receptor antagonism attenuates induced ischaemic tolerance in the gerbil hippocampusEuropean Journal of Pharmacology, 1999
- A Potential Role for Erythropoietin in Focal Permanent Cerebral Ischemia in MiceJournal of Cerebral Blood Flow & Metabolism, 1999
- Regulation of brain glucose transporters by glucose and oxygen deprivationMetabolism, 1999
- Ischemic Preconditioning and Brain Tolerance: Temporal Histological and Functional Outcomes, Protein Synthesis Requirement, and Interleukin-1 Receptor Antagonist and Early Gene ExpressionStroke, 1998
- Induction of tolerance in rat cortical neurons: hypoxic preconditioningFEBS Letters, 1997